Search Results - "Detti, S."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer by Spitaleri, G., Matei, D. V., Curigliano, G., Detti, S., Verweij, F., Zambito, S., Scardino, E., Rocco, B., Nolè, F., Ariu, L., De Pas, T., de Braud, F., De Cobelli, O.

    Published in Annals of oncology (01-03-2009)
    “…Background: There is a need for active agents with a better safety profile than docetaxel, yet good activity, for patients with hormone-refractory prostate…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20